Ye Lisha, Dittlau Katarina Stoklund, Sicart Adria, Janky Rekin''s, Van Damme Philip, Van Den Bosch Ludo
KU Leuven - University of Leuven, Department of Neurosciences and Leuven Brain Institute (LBI), Leuven, Belgium; Laboratory of Neurobiology, VIB Center for Brain & Disease Research, Leuven, Belgium.
VIB Nucleomics Core, Leuven, Belgium.
Neurobiol Dis. 2025 Mar;206:106815. doi: 10.1016/j.nbd.2025.106815. Epub 2025 Jan 28.
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterized by the selective and progressive loss of motor neurons, leading to gradual paralysis and death within 2 to 5 years after diagnosis. The exact underlying pathogenic mechanism(s) remain elusive. This is particularly the case for sporadic ALS (sALS), representing 90 % of cases, as modelling a sporadic disease is extremely difficult. We used human induced pluripotent stem cell (hiPSC)-derived motor neurons from sALS patients to investigate early disease mechanisms. The earliest phenotype that we observed were profound axonal defects including impaired axonal transport, defective axonal outgrowth and a reduced formation of neuromuscular junctions. Transcriptomic profiling revealed significant dysregulation in axon guidance pathways, with upregulation of specific axonal regeneration-inhibiting genes, such as EphA4 and DCC in sALS motor neurons. Our findings suggest that dysregulation of axon guidance pathways contributes to axonal defects and that this could play a crucial role in the pathogenesis of sALS.
肌萎缩侧索硬化症(ALS)是一种毁灭性的神经退行性疾病,其特征是运动神经元选择性地进行性丧失,导致在诊断后2至5年内逐渐瘫痪并死亡。确切的潜在致病机制仍然不明。对于占病例90%的散发性ALS(sALS)来说尤其如此,因为模拟一种散发性疾病极其困难。我们使用来自sALS患者的人诱导多能干细胞(hiPSC)衍生的运动神经元来研究早期疾病机制。我们观察到的最早表型是严重的轴突缺陷,包括轴突运输受损、轴突生长缺陷和神经肌肉接头形成减少。转录组分析显示轴突导向通路存在显著失调,sALS运动神经元中特定的轴突再生抑制基因如EphA4和DCC上调。我们的研究结果表明,轴突导向通路的失调导致轴突缺陷,这可能在sALS的发病机制中起关键作用。